December 8, 2020
These initial symptoms often escalate within 24-48 hours , leading to hypercalcemia (a dangerous buildup of calcium in the blood) and acute kidney failure

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604

Indeed, as current in vitro and in vivo toxicity testing methods are mainly used to evaluate the acute and subacute toxicity of metal-based NPs, nanotoxicity testing methods for chronic long-term NPs exposure, which are crucial for predicting chronic toxicity in humans, are still lacking
Yes since the additional compounds target fat metabolism and liver support while B12 alone does not
About our UK business : B12 injections + Aesthetics skin vitamin ampoules B12 Supplies was set up to deliver excellent quality aesthetics and skin injections as UK Wholesalers to the Beauty industry, shipping internationally